The Business Research Company’s report on the Hematopoietic Stem Cell Transplantation Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
#How have key drivers contributed to the rapid growth of the hematopoietic stem cell transplantation market?
The increased frequency of blood cancer is expected to propel the growth of the hematopoietic stem cell transplantation market. A group of malignancies that impact the development and operation of blood cells are referred to as blood cancers. Leukemia, lymphoma, and myeloma are the three main types of blood cancer. By replacing stem cells and bone marrow cells that have been killed by the malignancy, hematopoietic stem cell transplantation is generally used to treat blood cancer. These new stem cells can then move to the bone marrow and start creating new blood cells. So, these factors boost the hematopoietic stem cell transplantation market. For instance, in August 2022, according to the report shared by Blood Cancer UK, a UK-based non-profit organization, there are 41,000 blood cancer cases identified each year, making blood cancer the sixth most prevalent malignancy in the UK. Blood cancer, which affects one in 16 men and one in 22 women at some time in their lives, will afflict around 250,000 people in the UK in 2022. Additionally, more than 500 children under the age of 15 are affected by blood cancer each year. 400 of them have pediatric leukemia, and 100 of them have lymphoma. Therefore, the increased frequency of blood cancer drives the hematopoietic stem cell transplantation market.
Access Your Free Sample of the Global Hematopoietic Stem Cell Transplantation Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10445&type=smp
How has the hematopoietic stem cell transplantation market size evolved, and what are the latest forecasts for its expansion?
The hematopoietic stem cell transplantation market size has grown strongly in recent years. It will grow from$4.68 billion in 2024 to $5.12 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to early transplantation techniques, limited indications and donor sources, advancements in conditioning regimens, emergence of allogeneic transplants, regulatory milestones
The hematopoietic stem cell transplantation market size is expected to see rapid growth in the next few years. It will grow to “$7.73 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to expanded treatment indications, donor source diversification, personalized medicine and genomics, regulatory changes and guidelines, market expansion and accessibility. Major trends in the forecast period include advancements in transplant techniques, expansion of indications, emerging cellular therapies, donor diversification, precision medicine approach.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10445&type=smp
Which major companies dominate the hematopoietic stem cell transplantation market?
Major companies operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.
What trends will shape the future of the hemato oncology testing market?
Product approvals are a key trend gaining popularity in the hematopoietic stem cell transplantation market. Major companies operating in the hematopoietic stem cell transplantation market are adopting product approvals to sustain their position in the market. For instance, in April 2022, Priothera Ltd., an Ireland-based late-clinical stage biotechnology company, received the United States Food and Drug Administration (FDA) clearance of an investigational new drug (IND) to begin an allogeneic hematopoietic stem cell transplant (HSCT) Phase IIb/III research study with mocravimod in patients with acute myeloid leukemia (AML). Mocravimod is a synthetic sphingosine 1-phosphate receptor (S1PR) modulator, also known as KRP203. Phase I and Phase II trials have evaluated the safety, tolerability, and effectiveness of this unique experimental medication for several autoimmune diseases.
Which region dominates the hematopoietic stem cell transplantation market, and what factors contribute to its leadership?
North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
How is the hematopoietic stem cell transplantation market segmented, and which segment holds the largest share?
The hematopoietic stem cell transplantation market covered in this report is segmented –
1) By Type: Allogeneic, Autologous
2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders
3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant
4) By End User: Hospital Pharmacy, Retail Pharmacy, Specialty Clinics
Subsegments:
1) By Allogeneic: Matched Related Donor Transplantation, Matched Unrelated Donor Transplantation, Cord Blood Transplantation
2) By Autologous: Peripheral Blood Stem Cell Transplantation, Bone Marrow Stem Cell Transplantation
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10445
How is the hematopoietic stem cell transplantation market defined?
Hematopoietic stem cell transplantation (HSCT) refers to the process of a medical procedure that is used to treat various blood and bone marrow disorders, such as certain genetic disorders and autoimmune diseases. The procedure involves replacing a patient’s damaged or diseased bone marrow with healthy stem cells from a donor, which then grow and produce new blood cells in the patient’s body. These stem cells can be obtained from bone marrow, peripheral blood, or umbilical cord blood.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
